Mario Alberto Accardi Centessa Pharmaceuticals PLC (CNTA) insider trading activity

CNTA Quotes by TradingView

Mario Alberto Accardi is President, Orexin Program of Centessa Pharmaceuticals plc. Currently has a direct ownership of 207,566 shares of CNTA, which is worth approximately $4.33 Million. The most recent transaction as insider was on Aug 01, 2025, when has been sold 597 shares (Ordinary Shares) at a price of $17.17 per share, resulting in proceeds of $10,250. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 208K
n/a 3M change
n/a 12M change
Total Value Held $4.33 Million

Mario Alberto Accardi Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 01 2025
SELL
Payment of exercise price or tax liability
$10,250 $17.17 p/Share
597 Reduced 0.29%
207,566 Ordinary Shares
Jul 29 2025
SELL
Open market or private sale
$126,744 $15.23 p/Share
8,322 Reduced 3.84%
208,163 Ordinary Shares
Jun 24 2025
SELL
Open market or private sale
$210,000 $14.0 p/Share
15,000 Reduced 6.48%
216,485 Ordinary Shares
Jun 24 2025
BUY
Exercise of conversion of derivative security
$57,750 $3.85 p/Share
15,000 Added 6.09%
231,485 Ordinary Shares
MAA

Mario Alberto Accardi

President, Orexin Program
Cheshire, X0

Track Institutional and Insider Activities on CNTA

Follow Centessa Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

News

Receive news related to Centessa Pharmaceuticals plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CNTA